NDC 0071-0237

Zarontin

Ethosuximide

Zarontin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Parke-davis Div Of Pfizer Inc. The primary component is Ethosuximide.

Product ID0071-0237_a930d786-1b6a-4a75-8d39-70d1d99c1ac2
NDC0071-0237
Product TypeHuman Prescription Drug
Proprietary NameZarontin
Generic NameEthosuximide
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2000-09-22
Marketing CategoryNDA / NDA
Application NumberNDA012380
Labeler NameParke-Davis Div of Pfizer Inc
Substance NameETHOSUXIMIDE
Active Ingredient Strength250 mg/1
Pharm ClassesAnti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0071-0237-24

100 CAPSULE in 1 BOTTLE (0071-0237-24)
Marketing Start Date2000-09-22
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0071-0237-24 [00071023724]

Zarontin CAPSULE
Marketing CategoryNDA
Application NumberNDA012380
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2000-09-22

Drug Details

Active Ingredients

IngredientStrength
ETHOSUXIMIDE250 mg/1

OpenFDA Data

SPL SET ID:0e008f33-70a1-4bc6-b3a0-d45214418ab6
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197682
  • 201737

    • Pharmacological Class

    • Anti-epileptic Agent [EPC]
    • Decreased Central Nervous System Disorganized Electrical Activity [PE]
    • Anti-epileptic Agent [EPC]
    • Decreased Central Nervous System Disorganized Electrical Activity [PE]

    NDC Crossover Matching brand name "Zarontin" or generic name "Ethosuximide"

    NDCBrand NameGeneric Name
    0071-0237ZarontinEthosuximide
    0071-2418ZarontinEthosuximide
    0093-9660EthosuximideEthosuximide
    0121-0670ETHOSUXIMIDEETHOSUXIMIDE
    23155-532ETHOSUXIMIDEETHOSUXIMIDE
    42806-711EthosuximideEthosuximide
    46672-641ethosuximideethosuximide
    59762-2250EthosuximideEthosuximide
    59762-2350EthosuximideEthosuximide
    61748-024EthosuximideEthosuximide
    61748-025EthosuximideEthosuximide
    63629-8005EthosuximideEthosuximide
    64380-878ETHOSUXIMIDEETHOSUXIMIDE
    68382-443ethosuximideethosuximide
    69387-108EthosuximideEthosuximide
    69452-152EthosuximideEthosuximide

    Trademark Results [Zarontin]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ZARONTIN
    ZARONTIN
    72078062 0704519 Live/Registered
    Parke, Davis & Company
    1959-07-20
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.